These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10654919)

  • 1. Aflatoxin and liver cancer.
    Jackson PE; Groopman JD
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):545-55. PubMed ID: 10654919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oltipraz chemoprevention trial in Qidong, Jiangsu Province, People's Republic of China.
    Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Li YF; Fang X; Yu LY; De Flora S; Jacobson LP; Zarba A; Egner PA; He X; Wang JS; Chen B; Enger CL; Davidson NE; Gordon GB; Gorman MB; Prochaska HJ; Groopman JD; Muñoz A; Kensler TW
    J Cell Biochem Suppl; 1997; 28-29():166-73. PubMed ID: 9589363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China.
    Wang JS; Shen X; He X; Zhu YR; Zhang BC; Wang JB; Qian GS; Kuang SY; Zarba A; Egner PA; Jacobson LP; Muñoz A; Helzlsouer KJ; Groopman JD; Kensler TW
    J Natl Cancer Inst; 1999 Feb; 91(4):347-54. PubMed ID: 10050868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
    Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
    Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure biomarkers in chemoprevention studies of liver cancer.
    Wild CP; Turner PC
    IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keap1 eye on the target: chemoprevention of liver cancer.
    Yates MS; Kensler TW
    Acta Pharmacol Sin; 2007 Sep; 28(9):1331-42. PubMed ID: 17723167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes.
    Jacobson LP; Zhang BC; Zhu YR; Wang JB; Wu Y; Zhang QN; Yu LY; Qian GS; Kuang SY; Li YF; Fang X; Zarba A; Chen B; Enger C; Davidson NE; Gorman MB; Gordon GB; Prochaska HJ; Egner PA; Groopman JD; Muñoz A; Helzlsouer KJ; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):257-65. PubMed ID: 9107431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.
    Kensler TW; Egner PA; Wang JB; Zhu YR; Zhang BC; Lu PX; Chen JG; Qian GS; Kuang SY; Jackson PE; Gange SJ; Jacobson LP; Muñoz A; Groopman JD
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S310-8. PubMed ID: 15508099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk.
    Groopman JD; Johnson D; Kensler TW
    Cancer Biomark; 2005; 1(1):5-14. PubMed ID: 17192028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
    Wogan GN; Kensler TW; Groopman JD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.
    Wang LY; Hatch M; Chen CJ; Levin B; You SL; Lu SN; Wu MH; Wu WP; Wang LW; Wang Q; Huang GT; Yang PM; Lee HS; Santella RM
    Int J Cancer; 1996 Sep; 67(5):620-5. PubMed ID: 8782648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa.
    Turner PC; Sylla A; Diallo MS; Castegnaro JJ; Hall AJ; Wild CP
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S441-8. PubMed ID: 12534775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary prevention model of liver cancer in rural China].
    Qu CF; Chen TY; Wang YT; Yao HY; Chen K; Zhu J; Chen WQ; He H
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):481-489. PubMed ID: 30060354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
    Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
    Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.